International Conference on Pediatric Hematology and Blood Diseases
(ICPHBD-26)

31st October 2026 || Kolkata - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Pediatric Hematology and Blood Diseases (ICPHBD), scheduled to be held on 31st October 2026 in Kolkata, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Hematology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Pediatric Anemia Management
    This track will explore innovative strategies and clinical practices for the diagnosis and management of anemia in pediatric populations. Emphasis will be placed on evidence-based approaches and the integration of new therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Transfusion Protocols in Pediatric Hematology
    This session will focus on the latest guidelines and best practices for blood transfusion in children with hematological disorders. Discussions will include risk assessment, patient safety, and the impact of transfusion on clinical outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Clinical Research in Pediatric Blood Diseases
    This track will highlight recent clinical trials and research initiatives aimed at improving outcomes for children with blood diseases. Participants will engage in discussions about the challenges and opportunities in pediatric hematology research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Diagnostics in Pediatric Hematology
    This session will cover the latest advancements in diagnostic techniques for pediatric hematological disorders. Topics will include laboratory innovations, genetic testing, and the role of biomarkers in early detection. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Laboratory Techniques in Hematology
    This track will delve into cutting-edge laboratory techniques used in the diagnosis and management of pediatric blood diseases. Participants will learn about the application of molecular methods and automation in clinical laboratories. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Molecular Studies in Pediatric Hematology
    This session will focus on the role of molecular biology in understanding pediatric hematological disorders. Discussions will include genetic predispositions, pathophysiology, and the potential for targeted therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Translational Research in Hematology
    This track will emphasize the importance of translational research in bridging the gap between laboratory findings and clinical practice in pediatric hematology. Participants will explore case studies that illustrate successful translational approaches. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Patient Care Models in Pediatric Hematology
    This session will examine innovative patient care models that enhance the management of children with blood diseases. Emphasis will be placed on multidisciplinary approaches and family-centered care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 09 – Emerging Therapies in Pediatric Hematology
    This track will explore novel therapeutic agents and treatment modalities currently under investigation for pediatric hematological disorders. Participants will discuss the implications of these therapies on clinical practice and patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Ethical Considerations in Pediatric Hematology Research
    This session will address the ethical challenges and considerations involved in conducting research with pediatric populations suffering from blood diseases. Discussions will focus on informed consent, risk-benefit analysis, and the role of ethics committees. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Global Perspectives on Pediatric Hematology
    This track will provide insights into the global challenges and advancements in pediatric hematology. Participants will discuss disparities in care, access to treatments, and collaborative efforts to improve outcomes worldwide. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228